1. Paterson DL, Swindells S . Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000; 133 (Suppl. 1): 21–30.
2. Mannheimer S, Friedland G, Matts J, Child C, Chesney M . The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. Clin Infect Dis 2002; 34: 1115–1121.
3. McNabb J, Ross JW, Abriola K, Turley C, Nightingale CH, Nicola DP . Adherence to highly active antiretroviral therapy predicts virologic outcome at an inner-city human immunodeficiency virus clinic. Clin Infect Dis 2001; 33: 700–705.
4. Ickovics JR, Cameron A, Zackin R, Bassett R, Chesney M, Johnson V et al. Consequences and determinants of adherence to antiretroviral medication: results from adult AIDS Clinical Trials Group protocol 370. Antivir Therapy 2002; 7: 185–193.
5. AIDSinfo and U.S. Department of Health and Human Services Office of AIDS Research Advisory Council. Panel on treatment of HIV-infected pregnant women and prevention of perinatal transmission: Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States 2014 Available at http://aidsinfo.nih.gov/contentfiles/lvguidelines/PerinatalGL.pdf. (accessed on 20 January 2015).